HF
ADPT icon

HRT Financial’s Adaptive Biotechnologies ADPT Stock Holding History

HRT Financial’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.1M Buy
795,168
+663,927
+506% +$10.2M 0.03% 541
2026
Q1 		$1.82M Buy
131,241
+7,011
+6% +$112K ﹤0.01% 1676
2025
Q4 		$2.02M Buy
+124,230
New +$2.03M 0.01% 1301
2025
Q1 		– Sell
-98,357
Closed -$589K – 2455
2024
Q4 		$589K Buy
98,357
+53,388
+119% +$294K ﹤0.01% 1359
2024
Q3 		$230K Buy
+44,969
New +$196K ﹤0.01% 1913
2023
Q3 		– Sell
-16,145
Closed -$108K – 2327
2023
Q2 		$108K Sell
16,145
-89,783
-85% -$668K ﹤0.01% 1957
2023
Q1 		$935K Sell
105,928
-21,422
-17% -$189K 0.01% 990
2022
Q4 		$972K Sell
127,350
-64,518
-34% -$502K 0.01% 980
2022
Q3 		$1.37M Sell
191,868
-20,615
-10% -$194K 0.01% 757
2022
Q2 		$1.72M Buy
212,483
+4,755
+2% +$41.8K 0.02% 636
2022
Q1 		$2.88M Buy
+207,728
New +$3.27M 0.02% 471
2021
Q2 		– Sell
-67,955
Closed -$2.73M – 2772
2021
Q1 		$2.73M Buy
+67,955
New +$3.68M 0.03% 468

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

HRT Financial's ADPT Position: Q2 2026 in Review

HRT Financial increased its Adaptive Biotechnologies (ADPT) stake by 506% in Q2 2026, buying an estimated $10.2M and bringing the position to 795,168 shares worth $17.1M. The position accounts for 0.03% of the portfolio, ranked #541.

HRT Financial first reported a position in ADPT in Q1 2021 and has held it in 12 quarters since. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • HRT Financial held 795,168 shares of Adaptive Biotechnologies worth $17.1M as of Q2 2026.
  • HRT Financial bought 663,927 Adaptive Biotechnologies shares in Q2 2026, an estimated $10.2M.
  • Adaptive Biotechnologies made up 0.03% of HRT Financial's portfolio in Q2 2026, its #541 holding.
  • HRT Financial first reported a position in Adaptive Biotechnologies in Q1 2021 and has held it in 12 quarters since.
  • 300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.